Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370313 · ClinicalTrials.gov registry record · NA
The Impact of Innovative Tax Proposals on Purchase Patterns
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 285
- Enrollment target
NCT05370313: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT05370313 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 285 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05370313, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 285 participants
- Enrollment target
Study Summary
This study will investigate the effect of four tax proposals (i.e. Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-related taxes) on tobacco product purchasing patterns.
Primary Outcome
Purchasing of high-tax tier products in the ETM conditions will be fit to a commonly used exponential demand model that quantifies the relationship between the multiplicative tax factor (e.g., 2 times base tax rate) and purchasing of high-tax tier products. This demand analysis (which assumes a negative association between price and purchasing) will be used in the high-tax tier products because participants will be conventional cigarette smokers and these products (when available) will always be
Interventions
- BEHAVIORAL Market Price Condition (control)
- BEHAVIORAL Tobacco Parity Tax Condition
- BEHAVIORAL Nicotine-Content Tax Condition
- BEHAVIORAL Harm-Reduction Tax Condition
- BEHAVIORAL Modified Risk Tobacco Product (MRTP) Tax Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2023-04-11 |
| Est. Completion | 2025-06-10 |
| Phase | NA |
What the finished NCT05370313 record still lists
NCT05370313 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 5 interventions - of which Market Price Condition (control) is the first listed.
NCT05370313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05370313 about?
NCT05370313 is a clinical study titled "The Impact of Innovative Tax Proposals on Purchase Patterns". This study will investigate the effect of four tax proposals (i.e. Tobacco Parity, Nicotine-Content, Harm-Reduction, and Modified Risk Tobacco Product-related taxes) on tobacco product purchasing patterns.
What is the current status of trial NCT05370313?
This trial is currently completed. It is a NA study. The enrollment target is 285 participants. The study started on 2023-04-11. Estimated completion is 2025-06-10.
What interventions are being tested in trial NCT05370313?
The interventions under investigation include: Market Price Condition (control) (BEHAVIORAL), Tobacco Parity Tax Condition (BEHAVIORAL), Nicotine-Content Tax Condition (BEHAVIORAL), Harm-Reduction Tax Condition (BEHAVIORAL), Modified Risk Tobacco Product (MRTP) Tax Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT05370313?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05370313's enrollment target sits among peer trials
285 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI